Standout Papers

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome 2023 2026 2024116
  1. CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome (2023)
    Ann‐Christin Pecher, Luca Hensen et al. JAMA

Immediate Impact

25 standout
Sub-graph 1 of 9

Citing Papers

Pancreatic cancer
2025 Standout
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
2 intermediate papers

Works of K. Lutz being referenced

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
2023 Standout
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)
2021

Author Peers

Author Last Decade Papers Cites
K. Lutz 75 95 59 76 8 239
Ghada Khatib 44 68 66 58 14 233
Kalpana Devaraj 36 62 64 47 8 210
Gunnar Olsson 66 25 91 77 10 299
Tanja C. Stam 55 45 41 33 10 268
Davis X. Yao 142 144 42 27 10 298
Mayur Parepally 85 74 122 72 8 299
Mirela Stancu 46 126 116 98 7 281
Lei Liu 27 148 39 76 11 277
Luigi Leo 146 129 22 70 10 280
M. Sklair-Levy 84 28 87 79 9 296

All Works

Loading papers...

Rankless by CCL
2026